Progress of research in immune mechanism of human cytomegalovirus evasion of natural killer cells Reviewer: SUN Min, Reviser: QIAN Jihong (Department of Neonatology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China)
[1] 周光炎. 免疫学原理 [M]. 上海：上海科学技术出版社,2007：41-45. [2] Charoudeh HN，Terszowski G，Czaja K，et al. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection [J]. Eur J Immunol，2013，43(2)：480-487. [3] Jamil KM，Khakoo SI. KIR/HLA interactions and pathogen immunity [J]. J Biomed Biotechnol，2011：298348. [4] Moretta L，Locatelli F，Pende D，et al. Killer Ig-like receptor-media-ted control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation [J]. Blood，2011，117(3)：764-771. [5] Guma M，Busch LK，Salazar-Fontana LI，et al. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells [J]. Eur J Immunol，2005，35(7)：2071-2080. [6] Babic M，Krmpotic A，Jonjic S. All is fair in virus-host interactions：NK cells and cytomegalovirus [J]. Trends Mol Med，2011，17(11)：677-685. [7] Loenen WA，Bruggeman CA，Wiertz EJ. Immune evasion by human cytomegalovirus：lessons in immunology and cell biology [J]. Semin Immunol， 2001，13(1)：41-49. [8] Prod'homme V，Tomasec P，Cunningham C，et al. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18 [J]. J Immunol，2012，188(6)：2794-2804. [9] Wilkinson GW，Tomasec P，Stanton RJ，et al. Modulation of natural killer cells by human cytomegalovirus [J]. J Clin Virol，2008，41(3)：206-212. [10] Klumkrathok K，Jumnainsong A，Leelayuwat C. Allelic MHC class I chain related B (MICB) molecules affect the binding to the human cytomegalovirus (HCMV) unique long 16 (UL16) protein：implications for immune surveillance [J]. J Microbiol，2013，51(2)：241-246. [11] Muller S，Zocher G，Steinle A，et al. Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands [J]. PLoS Pathog，2010，6(1)：e1000723. [12] Li NL，Davidson CL，Humar A，et al. Modulation of the inhibitory receptor leukocyte Ig-like receptor 1 on human natural killer cells [J]. Front Immunol，2011，2：46. [13] Engel P，Angulo A. Viral immunomodulatory proteins：usurping host genes as a survival strategy [J]. Adv Exp Med Biol，2012，738：256-276. [14] Kim Y，Park B，Cho S，et al. Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses [J]. PLoS Pathog，2008，4(8)：e1000123. [15] Ashiru O，Bennett NJ，Boyle LH，et al. NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142 [J]. J Virol，2009，83(23)：12345-12354. [16] David R. Immune evasion：UL141 keeps HCMV in charge [J]. Nat Rev Microbiol，2013，11(5)：297. [17] Prod'homme V，Sugrue DM，Stanton RJ，et al. Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112 [J]. J Gen Virol，2010，91(Pt 8)：2034-2039. [18] Grey F，Nelson J. Identification and function of human cytomegalovirus microRNAs [J]. J Clin Virol，2008，41(3)：186-191. [19] Goodrum F，Caviness K，Zagallo P. Human cytomegalovirus persistence [J]. Cell Microbiol，2012，14(5)：644-655. [20] Nachmani D，Stern-Ginossar N，Sarid R，et al. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells [J]. Cell Host Microbe，2009，5(4)：376-385. [21] Nachmani D，Lankry D，Wolf DG，et al. The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular micro-RNA to escape immune elimination [J]. Nat Immunol，2010，11(9)：806-813. [22] Wagner CS，Walther-Jallow L，Buentke E，et al. Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells [J]. J Leukoc Bio，2008，3(1)：56-63. [23] Rolle A，Olweus J. Dendritic cells in cytomegalovirus infection：viral evasion and host countermeasure [J]. APMIS，2009，117(5-6)：413-426. [24] Bego MG，St Jeor S. Human cytomegalovirus infection of cells of hematopoietic origin：HCMV-induced immunosuppression，immune evasion，and latency [J]. Exp Hematol，2006，34(5)：555-570. [25] Soland MA，Bego MG，Colletti E，et al. Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins [J]. PLoS One，2012，7(5)：e36163. [26] Magri G，Muntasell A，Romo N，et al. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected mye-loid dendritic cells overcoming viral immune evasion strategies [J]. Blood，2011，117(3)：848-856. [27] Jackson SE，Mason GM，Wills MR. Human cytomegalovirus immunity and immune evasion [J]. Virus Res，2011，157(2)：151-160. [28] Slavuljica I，Busche A，Babic M，et al. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties [J]. J Clin Invest，2010，120(12)：4532-4545.
